COMMUNIQUÉS West-GlobeNewswire

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
10/03/2026
— The new pricing structure is made available as of February for 26,63 DKK per day at pharmacies throughout Denmark AMSTERDAM, March 10, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical [...]
VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland
10/03/2026
— The new pricing structure is made available as of February for 32,13 SEK per day at pharmacies throughout Sweden AMSTERDAM, March 10, 2026 (GLOBE NEWSWIRE) -- VIVUS BV, a subsidiary of VIVUS LLC, a biopharmaceutical [...]
Imprivata Introduces Agentic Identity Management to Secure and Govern AI Agents in Healthcare
10/03/2026
New capabilities enable healthcare organizations to deploy AI agents that improve clinician productivity while maintaining secure, compliant access across modern and legacy systems WALTHAM, Mass., March 10, 2026 (GLOBE [...]
Nominations Now Open for PerfectServe’s Sixth Annual Nurses of Note Awards Program
10/03/2026
2026 program to highlight nurse leadership and excellence in clinical innovation, patient-centered care, culture & retention, and care team communication MIAMI, March 10, 2026 (GLOBE NEWSWIRE) -- PerfectServe ® , a [...]
Assemblée générale annuelle 2026 de Roche
10/03/2026
Adoption de toutes les propositions du Conseil d’administration Réélection de Severin Schwan à la présidence du Conseil d’administration ; confirmation de tous les autres membres du Conseil d’administration qui se sont [...]
Roche Annual General Meeting 2026
10/03/2026
Shareholders approved all proposals of the Board of Directors Severin Schwan re-elected as Chairman of the Board of Directors; all other Board members standing for election were confirmed 39th consecutive dividend [...]
Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA
10/03/2026
Deramiocel has the potential to become the first therapy to address both skeletal and cardiac manifestations of Duchenne muscular dystrophy BLA supported by positive pivotal HOPE-3 Phase 3 results, including achievement [...]
Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA
10/03/2026
Deramiocel has the potential to become the first therapy to address both skeletal and cardiac manifestations of Duchenne muscular dystrophy BLA supported by positive pivotal HOPE-3 Phase 3 results, including achievement [...]
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails
10/03/2026
TEL AVIV, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
Baylor Genetics Enhances Whole Genome Sequencing Test with Optical Genome Mapping and Long‑Read Sequencing as Supplemental Technologies
10/03/2026
New technologies enable enhanced short tandem repeat analysis, complex structural variant analysis, and methylation analysis of FMR1 HOUSTON, March 10, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading diagnostic [...]
GLP Diet Review: A Personalized App Designed to Support GLP-1 Weight Loss Journeys
10/03/2026
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- GLP Diet introduces a personalized wellness app designed to support individuals using GLP-1 weight-loss medications. The app combines structured nutrition guidance, light [...]
Shoreline Recovery Center Experts Announce New Therapeutic Approach In Addiction Recovery
10/03/2026
Shoreline Recovery Center experts warn rebuilding family relationship with loved ones is crucial in recovery SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- The disease of addiction has a domino effect – deeply impacting [...]
Experts at Park Mental Health Announce New Therapeutic Approach: Highlighting the Role of Community Support in Recovery
10/03/2026
Park Mental Health highlights the importance of supportive relationships in mental health journey SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- It can be a difficult task to support an individual struggling with mental [...]
Validic Announces Integration with Salesforce Health Cloud to Advance Connected Care and Value-Based Engagement
10/03/2026
New integration unifies remote patient monitoring and wearable data within Salesforce Health Cloud to enable proactive care management across health systems, life sciences, and payers LAS VEGAS, March 10, 2026 (GLOBE [...]
Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
10/03/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, recently announced the launch of ALLEVYN ♢ COMPLETE CARE Foam Dressing, featuring proprietary technologies and performance backed by a portfolio of [...]
Coloplast A/S - Allocation of Share Options
10/03/2026
Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives [...]
PolTREG moves forward with the European registration process for TREG therapy in type 1 diabetes
10/03/2026
The European Medicines Agency (EMA) has officially qualified PolTREG to submit an application for marketing authorization in the European Union for the PolTREG-T1D cell preparation. GDAŃSK, Poland, March 10, 2026 (GLOBE [...]
EnteroBiotix Announces Completion of Enrolment in Phase 2a Trial Evaluating EBX-102-02 Prior to Allogeneic Stem Cell Transplantation
10/03/2026
GLASGOW, United Kingdom, March 10, 2026 (GLOBE NEWSWIRE) -- EnteroBiotix, a clinical-stage biopharmaceutical company developing best-in-class microbiome therapies, today announced that the investigator-initiated Phase [...]
TECVAYLI®▼ (teclistamab) monotherapy application submitted to the EMA for relapsed/refractory multiple myeloma after at least one prior therapy
10/03/2026
Application supported by Phase 3 data reinforcing teclistamab regimens as a potential standard of care after at least one prior therapy 1 Teclistamab monotherapy delivered superior progression-free survival and overall [...]

Pages